UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

Journal of cutaneous medicine and surgery, 2019-01, Vol.23 (1), p.50-74

2019

Volltextzugriff (PDF)

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Gut, 2023-08, Vol.72 (8), p.1462-1471

2023

Volltextzugriff (PDF)

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity

JGH open, 2018-10, Vol.2 (5), p.201-206

2018

Volltextzugriff (PDF)

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Inflammatory bowel diseases, 2019-01, Vol.25 (1), p.1-13

2019

Volltextzugriff (PDF)

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

Journal of rheumatology, 2019-07, Vol.46 (7), p.751-754

2019

Volltextzugriff (PDF)

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

Journal of gastroenterology and hepatology, 2021-10, Vol.36 (10), p.2803-2812

2021

Volltextzugriff (PDF)

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 – Inflammatory bowel disease task force meeting

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.639-644

2011

Volltextzugriff (PDF)

Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials

Inflammatory bowel diseases, 2006-10, Vol.12 (10), p.979-994

2006

Volltextzugriff (PDF)

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2018-07, Vol.24 (8), p.1808-1814

2018

Volltextzugriff (PDF)

Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?

Inflammatory bowel diseases, 2018-03, Vol.24 (4), p.669-670

Steinhart, A Hillary

2018

Volltextzugriff (PDF)

Traditional corticosteroids for induction of remission in Crohn's disease

Cochrane database of systematic reviews, 2008-04 (2), p.CD006792

2008

Volltextzugriff (PDF)

Clinical guidelines for the medical management of left‐sided ulcerative colitis and ulcerative proctitis: Summary statement

Inflammatory bowel diseases, 2006-10, Vol.12 (10), p.972-978

2006

Volltextzugriff (PDF)

Choosing Therapies in Ulcerative Colitis

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (1), p.9-21

2024

Volltextzugriff (PDF)

Oral budesonide for induction of remission in ulcerative colitis

Cochrane database of systematic reviews, 2015-10, Vol.2015 (10), p.CD007698

2015

Volltextzugriff (PDF)

Maintenance of remission in inflammatory bowel disease using omega‐3 fatty acids (fish oil): A systematic review and meta‐analyses

Inflammatory bowel diseases, 2011-01, Vol.17 (1), p.336-345

2011

Volltextzugriff (PDF)

Preventive care for a 35-year-old woman with inflammatory bowel disease

Canadian Medical Association journal (CMAJ), 2017-02, Vol.189 (6), p.E243-E244

2017

Volltextzugriff (PDF)

Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

Science (American Association for the Advancement of Science), 2006-12, Vol.314 (5804), p.1461-1463

2006

Volltextzugriff (PDF)

Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis

Cochrane database of systematic reviews, 2010-01 (1), p.CD004115

2010

Volltextzugriff (PDF)

Budesonide for induction of remission in Crohn's disease

Cochrane database of systematic reviews, 2015-06, Vol.2015 (6), p.CD000296

2015

Volltextzugriff (PDF)

Methotrexate for the Treatment of Crohn's Disease

The New England journal of medicine, 1995-02, Vol.332 (5), p.292-297

1995

Volltextzugriff (PDF)

Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

American journal of clinical dermatology, 2021-03, Vol.22 (2), p.139-147

2021

Volltextzugriff (PDF)

Diphyllobothrium latum: a case of an incidental finding

World journal of gastroenterology : WJG, 2007-03, Vol.13 (12), p.1875

2007

Volltextzugriff (PDF)

Design issues and outcomes in IBD clinical trials

Inflammatory bowel diseases, 2005-11, Vol.11 (S1), p.S22-S28

2005

Volltextzugriff (PDF)

Identification of Target Golimumab Levels in Maintenance Therapy of Crohn’s Disease and Ulcerative Colitis Associated With Mucosal Healing

Inflammatory bowel diseases, 2020-04, Vol.26 (5), p.766-773

2020

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaMale

ThemaYoung Adult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(136)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 – Inflammatory bowel disease task force meeting

Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?

Traditional corticosteroids for induction of remission in Crohn's disease

Clinical guidelines for the medical management of left‐sided ulcerative colitis and ulcerative proctitis: Summary statement

Choosing Therapies in Ulcerative Colitis

Oral budesonide for induction of remission in ulcerative colitis

Maintenance of remission in inflammatory bowel disease using omega‐3 fatty acids (fish oil): A systematic review and meta‐analyses

Preventive care for a 35-year-old woman with inflammatory bowel disease

Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis

Budesonide for induction of remission in Crohn's disease

Methotrexate for the Treatment of Crohn's Disease

Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

Diphyllobothrium latum: a case of an incidental finding

Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)

Design issues and outcomes in IBD clinical trials

Identification of Target Golimumab Levels in Maintenance Therapy of Crohn’s Disease and Ulcerative Colitis Associated With Mucosal Healing

Aktive Filter

Suchergebnisse filtern